Santander Holdings USA, Inc.10% Owner
Buy $588.7M of disclosed value in Santander Consumer USA Holdings $SC.
Buy
Market Actions for January 2022
Baker Bros. Advisors LP10% Owner
Buy $18.1M of disclosed value in Kodiak Sciences Inc $KOD.
Buy
Zauderer MauriceDirector, President, CEO
Buy $2.0M of disclosed value in Vaccinex, Inc. $VCNX.
Buy
Rozek Alexander BuffettDirector, 10% Owner
Buy $45.0M of disclosed value in Sky Harbour Group Corporation $SKYH-WT.
Buy
Friedberg AlbertDirector, 10% Owner
Buy $2.0M of disclosed value in Vaccinex, Inc. $VCNX.
Buy
Rozek Alexander BuffettDirector, 10% Owner
Buy $45.0M of disclosed value in Sky Harbour Group Corporation $SKYH.
Buy
Rozek Alexander BuffettDirector, 10% Owner
Buy $45.0M of disclosed value in Boston Omaha Corporation $BOC.
Buy
Goeddel David VDirector, 10% Owner
Buy $12.2M of disclosed value in NGM Biopharmaceuticals, Inc. $NGM.
Buy
Woodman NicholasDirector, CEO, Chair of the Board, 10% Owner
Sell $1.7M of disclosed value in GoPro Inc - Class A $GPRO.
Sell
Column Group L P10% Owner
Buy $12.2M of disclosed value in NGM Biopharmaceuticals, Inc. $NGM.
Buy
Davidson FrancisDirector, CEO
Sell $15.0M of disclosed value in Sonder Holdings Inc. $SONDQ.
Sell
Baker Bros. Advisors LP10% Owner
Buy $28.8M of disclosed value in Kodiak Sciences Inc $KOD.
Buy
China Investment Corp10% Owner
Sell $12.3M of disclosed value in TPG RE Finance Trust, Inc. $TRTX.
Sell
Ares Management LLC10% Owner
Sell $8.1M of disclosed value in California Resources Corporation $CRC.
Sell
Orbimed Advisors LLC10% Owner
Buy $2.0M of disclosed value in Passage Bio, Inc. $PASG.
Buy
Working Capital AdvisorsLtd.10% Owner
Buy $1.6M of disclosed value in Stitch Fix, Inc. $SFIX.
Buy
Gad ThomasDirector, See remarks
Sell $2M of disclosed value in Y-mAbs Therapeutics, Inc. $YMAB.
Sell
Wolchko J ScottDirector, President, CEO
Sell $1.6M of disclosed value in FATE THERAPEUTICS INC $FATE.
Sell
Bvf Partners L P/il10% Owner
Buy $14.1M of disclosed value in Repare Therapeutics Inc. $RPTX.
Buy
Orbimed Advisors LLC10% Owner
Buy $1.6M of disclosed value in Theseus Pharmaceuticals, Inc. $THRX.
Buy